BrainsWay’s Treatment for Decreasing Anxiety Among Depressed Patients is Now FDA-Cleared
BrainsWay, a global leader in advanced noninvasive neurostimulation treatments for mental health disorders, has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its Deep Transcranial…
Continue Reading
BrainsWay’s Treatment for Decreasing Anxiety Among Depressed Patients is Now FDA-Cleared